Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cytokeratin 18 anticorps

Cet anticorps anti-Cytokeratin 18 est un anticorps Souris Monoclonal détectant Cytokeratin 18 dans WB, IF, IHC (p), IP et EIA. Adapté pour Humain. Ce Primary Antibody a été cité dans 6+ publications.
N° du produit ABIN118968

Aperçu rapide pour Cytokeratin 18 anticorps (ABIN118968)

Antigène

Voir toutes Cytokeratin 18 (KRT18) Anticorps
Cytokeratin 18 (KRT18) (Keratin 18 (KRT18))

Reactivité

  • 294
  • 151
  • 126
  • 75
  • 65
  • 57
  • 53
  • 49
  • 39
  • 38
  • 34
  • 34
  • 34
  • 18
  • 9
  • 9
  • 7
  • 7
  • 4
  • 3
  • 2
  • 1
Humain

Hôte

  • 173
  • 160
  • 3
  • 1
  • 1
  • 1
Souris

Clonalité

  • 198
  • 138
  • 3
Monoclonal

Conjugué

  • 169
  • 30
  • 22
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Cet anticorp Cytokeratin 18 est non-conjugé

Application

  • 278
  • 165
  • 103
  • 102
  • 73
  • 57
  • 54
  • 54
  • 47
  • 40
  • 34
  • 31
  • 13
  • 8
  • 8
  • 7
  • 6
  • 4
  • 2
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Enzyme Immunoassay (EIA)

Clone

DC-10
  • Specificité

    The antibody reacts with Human Cytokeratin 18 (45 kDa). Cytokeratins are a member of intermediate filaments subfamily represented in epithelial tissues.

    Purification

    Affinity Chromatography on Protein A

    Immunogène

    Human breast carcinoma cell line PMC-42

    Isotype

    IgG1
  • Indications d'application

    Immunoprecipitation. Western Blotting (non-reducing conditions): 1-2 mg/mL, overnight in 4 °C. Positive control: HeLa human cervix carcinoma cell line MCF-7 human breast adenocarcinoma cell line. Sample preparation: Resuspend approx. 50 mil. cells in 1 mLcold Lysis buffer (1 % laurylmaltoside in 20 mM Tris/Cl, 100 mM NaCl pH 8.2, 50 mM NaF including Protease inhibitor Cocktail). Incubate 60 min on ice. Centrifuge to remove cell debris. Mix lysate with non- reducing SDS-PAGE sample buffer. SDS-PAGE (10 % separating gel). Immunohistochemistry (paraffin sections): 10 - 1:100. Positive tissue: epithelial tissue (skin). Immunocytochemistry. Positive control: MCF-7 human breast adenocarcinoma cell line HeLa human cervix carcinoma cell line. ELISA. Positive control: MCF-7 human breast adenocarcinoma cell line. Application note: The antibody DC-10 has been tested as the detection antibody in a sandwich ELISA for analysis of Cytokeratin 18 in combination with the clone C-04.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS, pH ~7.4, 15 mM Sodium Azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store the original vial at 2-8 °C. Stock solution and aliquots thereof should be stored at -20 °C.
  • Blumenthal, Giebel, Ummanni, Schlüter, Endlich, Endlich: "Morphology and migration of podocytes are affected by CD151 levels." dans: American journal of physiology. Renal physiology, Vol. 302, Issue 10, pp. F1265-77, (2012) (PubMed).

    Hachiya, Sriwiriyanont, Fujimura, Ohuchi, Kitahara, Takema, Kitzmiller, Visscher, Tsuboi, Boissy: "Mechanistic effects of long-term ultraviolet B irradiation induce epidermal and dermal changes in human skin xenografts." dans: The American journal of pathology, Vol. 174, Issue 2, pp. 401-13, (2009) (PubMed).

    Kirby, Beattie, Maroof, van Rooijen, Kaye: "SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophages." dans: The American journal of pathology, Vol. 175, Issue 3, pp. 1107-15, (2009) (PubMed).

    Lau, Mollnau, Eiserich, Freeman, Daiber, Gehling, Brümmer, Rudolph, Münzel, Heitzer, Meinertz, Baldus: "Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Issue 2, pp. 431-6, (2005) (PubMed).

    Vojt?sek, Stasková, Nenutil, Lauerová, Kovarík, Rejthar, Bártková, Bártek: "Monoclonal antibodies recognizing different epitopes of cytokeratin No.18." dans: Folia biologica, Vol. 35, Issue 6, pp. 373-82, (1990) (PubMed).

    Kovarík, Rejthar, Lauerová, Vojt?sek, Bártková: "Monoclonal antibodies against individual cytokeratins in the detection of metastatic spread." dans: International journal of cancer. Supplement = Journal international du cancer. Supplement, Vol. 3, pp. 50-5, (1989) (PubMed).

  • Antigène

    Cytokeratin 18 (KRT18) (Keratin 18 (KRT18))

    Autre désignation

    Cytokeratin 18

    Sujet

    Cytokeratins are a subfamily of intermediate filaments and characterized by remarkable biochemical diversity. Cytokeratins are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individual cytokeratin polypeptides are designated 1 to 20 and divided into the type I (acidic cytokeratins 9-20) and type II (basic to neutral cytokeratins 1-8) families. Cytokeratin 18 belongs to type I family (acidic cytokeratins).Synonyms: CK18, CYK18, Cell proliferation-inducing gene 46 protein, Cytokeratin-18, K18, KRT18, Keratin 18, Keratin type I cytoskeletal 18, Keratin-18

    ID gène

    3875

    NCBI Accession

    NP_000215

    UniProt

    P05783

    Pathways

    Apoptose, Caspase Cascade in Apoptosis
Vous êtes ici:
Chat with us!